Posted by ABMN Staff on Mar 19th, 2024
HC Wainwright reiterated their buy rating on shares of IN8bio (NASDAQ:INAB – Free Report) in a research report released on Friday, Benzinga reports. HC Wainwright currently has a $14.00 price target on the stock.
Separately,...
More of this article »